AnBogen Therapeutics
Developer of precision cancer therapeutics developed to address unmet medical needs and improve the lives of cancer patients globally. The company is devoted to bridging the gap between research and c...
Valuation
$0
Share Price
N/A
Total Raised
$19.8M
Last Round
N/A